# Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome

> **NCT02337933** · PHASE2 · COMPLETED · sponsor: **University of Guadalajara** · enrollment: 24 (actual)

## Conditions studied

- Metabolic Syndrome X

## Interventions

- **DRUG:** Ursolic acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02337933
- **Lead sponsor:** University of Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02337933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02337933, "Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02337933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*